Abstract: A method for treating effluent from hydrothermal liquification of feedstock that contains plastic oil, pyrolysis oil, synthetic oil or hydrocarbons distillates in a plastic recycle process using supercritical water as a reaction medium into a finished liquid hydrocarbon fuel by removing impurities such as i.e. silicon, chlorides, metals, heteroatoms, etc., in a pre-treatment zone and may be passed into a feed drum or a continuous mixed settler vessel. The feed is introduced into a hydrogen atmosphere reactor. The reactor effluent is passed to a separator for extracting product mixture by addition of make-up or recycled hydrogen to the separator. The overhead product mixture is water washed to remove sour water or salt. The separator effluent is passed to a distillation section for extracting a liquid fuel product stream. A portion of the hydro processing product stream may be recycled to the feed drum or the continuous mixed settler vessel, which reduces concentration of diolefins.

Abstract: Methods and systems for treating an olefin-containing stream are disclosed. The disclosed methods and systems are particularly suitable for treating an off-gas stream in a refining or petrochemical process, such as from a fluid catalytic cracker (FCC), coker, steam cracker, and the like. The stream is treated in an absorber column to reject lighter stream components and to absorb ethylene and/or propylene into a solvent. The solvent is typically isobutane. The enriched solvent stream from the absorber column is fed to an alkylation reactor, which reacts the dissolved olefin with the isobutane solvent to produce an alkylate product.

Abstract: Methods and systems for treating an olefin-containing stream are disclosed. The disclosed methods and systems are particularly suitable for treating an off-gas stream in a refining or petrochemical process, such as from a fluid catalytic cracker (FCC), coker, steam cracker, and the like. The stream is treated in an absorber column to reject lighter stream components and to absorb ethylene and/or propylene into a solvent. The solvent is typically isobutane. The enriched solvent stream from the absorber column is fed to an alkylation reactor, which reacts the dissolved olefin with the isobutane solvent to produce an alkylate product.

Abstract: The present disclosure relates to methods for selectively hydrogenating acetylene, to methods for starting up a selective hydrogenation reactor, and to hydrogenation catalysts useful in such methods. In one aspect, the disclosure provides a method for selectively hydrogenating acetylene, the method comprising contacting a catalyst composition with a process gas. The catalyst composition comprises a porous support, palladium, and one or more ionic liquids. The process gas includes ethylene, present in the process gas in an amount of at least 20 mol. %; acetylene, present in the process gas in an amount of at least 1 ppm; and 0 to 190 ppm or at least 600 ppm carbon monoxide. At least 90% of the acetylene present in the process gas is hydrogenated, and the selective hydrogenation is conducted without thermal runaway.

Abstract: The present disclosure relates to methods for selectively hydrogenating acetylene, to methods for starting up a selective hydrogenation reactor, and to hydrogenation catalysts useful in such methods. In one aspect, the disclosure provides a method for selectively hydrogenating acetylene, the method comprising contacting a catalyst composition with a process gas. The catalyst composition comprises a porous support, palladium, and one or more ionic liquids. The process gas includes ethylene, present in the process gas in an amount of at least 20 mol. %; and acetylene, present in the process gas in an amount of at least 1 ppm. At least 90% of the acetylene present in the process gas is hydrogenated, and the selective hydrogenation is conducted without thermal runaway. Notably, the process gas is contacted with the catalyst at a gas hourly space velocity (GHSV) based on total catalyst volume in one bed or multiple beds of at least 7,100 h?1.

Abstract: Methods and systems for treating an olefin-containing stream are disclosed. The disclosed methods and systems are particularly suitable for treating an off-gas stream in a refining or petrochemical process, such as from a fluid catalytic cracker (FCC), coker, steam cracker, and the like. The stream is treated in an absorber column to reject lighter stream components and to absorb ethylene and/or propylene into a solvent. The solvent is typically isobutane. The enriched solvent stream from the absorber column is fed to an alkylation reactor, which reacts the dissolved olefin with the isobutane solvent to produce an alkylate product.

Abstract: The present disclosure relates to methods for selectively hydrogenating acetylene, to methods for starting up a selective hydrogenation reactor, and to hydrogenation catalysts useful in such methods. In one aspect, the disclosure provides a variety of methods for starting up reactors for use in methods for selectively hydrogenating acetylene using a catalyst composition comprises a porous support, palladium, and one or more ionic liquids.

Abstract: The present disclosure relates to methods for selectively hydrogenating acetylene, to methods for starting up a selective hydrogenation reactor, and to hydrogenation catalysts useful in such methods. In one aspect, the disclosure provides a variety of methods for starting up reactors for use in methods for selectively hydrogenating acetylene using a catalyst composition comprises a porous support, palladium, and one or more ionic liquids.

Abstract: The present disclosure relates to methods for selectively hydrogenating acetylene, to methods for starting up a selective hydrogenation reactor, and to hydrogenation catalysts useful in such methods. In one aspect, the disclosure provides a method for selectively hydrogenating acetylene, the method comprising contacting a catalyst composition with a process gas. The catalyst composition comprises a porous support, palladium, and one or more ionic liquids. The process gas includes ethylene, present in the process gas in an amount of at least 20 mol. %; acetylene, present in the process gas in an amount of at least 1 ppm; and 0 to 190 ppm or at least 600 ppm carbon monoxide. At least 90% of the acetylene present in the process gas is hydrogenated, and the selective hydrogenation is conducted without thermal runaway.

Abstract: The present disclosure relates to methods for selectively hydrogenating acetylene, to methods for starting up a selective hydrogenation reactor, and to hydrogenation catalysts useful in such methods. In one aspect, the disclosure provides a method for selectively hydrogenating acetylene, the method comprising contacting a catalyst composition with a process gas. The catalyst composition comprises a porous support, palladium, and one or more ionic liquids. The process gas includes ethylene, present in the process gas in an amount of at least 20 mol. %; and acetylene, present in the process gas in an amount of at least 1 ppm. At least 90% of the acetylene present in the process gas is hydrogenated, and the selective hydrogenation is conducted without thermal runaway. Notably, the process gas is contacted with the catalyst at a gas hourly space velocity (GHSV) based on total catalyst volume in one bed or multiple beds of at least 7,100 h?1.

Abstract: Isoquinoline compounds with G are provided that influence, inhibit or reduce the action of a G-protein receptor kinase. Pharmaceutical compositions including therapeutically effective amounts of the isoquinoline compounds and pharmaceutically acceptable carriers are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions such as cancer, osteoporosis and glaucoma are also provided.

Abstract: Hydrazide compounds with GPCR desensitization inhibitory activity are provided that may be used to influence, inhibit or reduce the action of a G-protein receptor kinase. Pharmaceutical compositions including therapeutically effective amounts of the hydrazide compounds and pharmaceutically acceptable carriers are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions controlled or influenced by GPCRs are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions such as cancer, osteoporosis and glaucoma are also provided.